<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Among 16 cases clinicaly diagnosed as Adamantiadès-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome coming from various areas of Northern Greece, antigen HLA-B5 was found on 12, i.e. 75% instead of 18,5% in the <z:mpath ids='MPATH_458'>normal</z:mpath> population of the same areas (200 subjects were examined by Dr. Z </plain></SENT>
<SENT sid="1" pm="."><plain>Polymenidis in this thesis) </plain></SENT>
<SENT sid="2" pm="."><plain>On 3 other cases the antigen found was HLA-BW35 (belonging to group C4), while on the last one the antigen was HLA-B27 </plain></SENT>
<SENT sid="3" pm="."><plain>4 cases, suspicious for atypical Adamantiadès-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome, are reported in which the discovery of antigen HLA-B5 inhanced the clinical diagnosis of the syndrome and made possible the early application of suitable treatment (steroids, immunosupressors) </plain></SENT>
</text></document>